Markus Weigandt

625 total citations
19 papers, 512 citations indexed

About

Markus Weigandt is a scholar working on Pharmaceutical Science, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Markus Weigandt has authored 19 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmaceutical Science, 6 papers in Molecular Biology and 5 papers in Materials Chemistry. Recurrent topics in Markus Weigandt's work include Drug Solubulity and Delivery Systems (10 papers), Advanced Drug Delivery Systems (6 papers) and Protein purification and stability (5 papers). Markus Weigandt is often cited by papers focused on Drug Solubulity and Delivery Systems (10 papers), Advanced Drug Delivery Systems (6 papers) and Protein purification and stability (5 papers). Markus Weigandt collaborates with scholars based in Germany, Denmark and Italy. Markus Weigandt's co-authors include Achim Goepferich, Tobias Miller, Simon Geißler, Heike Bunjes, Reinhard Rachel, Ahmed Besheer, Stefan Fennrich, Thomas Härtung, Walter Mier and Thomas Montag-Lessing and has published in prestigious journals such as Journal of Controlled Release, Biomacromolecules and International Journal of Pharmaceutics.

In The Last Decade

Markus Weigandt

19 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Weigandt Germany 12 176 174 136 96 70 19 512
Sankalp Gharat India 10 187 1.1× 199 1.1× 126 0.9× 129 1.3× 66 0.9× 25 615
Othman Al-Hanbali Jordan 9 178 1.0× 136 0.8× 116 0.9× 93 1.0× 85 1.2× 13 508
Ruchit Trivedi United States 9 170 1.0× 218 1.3× 126 0.9× 93 1.0× 33 0.5× 10 632
Mahira Zeeshan Pakistan 15 213 1.2× 170 1.0× 206 1.5× 145 1.5× 75 1.1× 21 675
Shivani Saraf India 12 199 1.1× 206 1.2× 124 0.9× 126 1.3× 35 0.5× 27 497
Qiying Shen China 13 191 1.1× 164 0.9× 76 0.6× 206 2.1× 91 1.3× 20 540
Evren Gündoğdu Türkiye 16 192 1.1× 141 0.8× 218 1.6× 138 1.4× 91 1.3× 55 621
Nicola d’Avanzo Italy 14 181 1.0× 217 1.2× 102 0.8× 137 1.4× 36 0.5× 24 533
Girish Kore India 6 262 1.5× 276 1.6× 103 0.8× 185 1.9× 77 1.1× 6 666
Maedeh Koohi Moftakhari Esfahani Iran 19 305 1.7× 174 1.0× 101 0.7× 217 2.3× 95 1.4× 23 656

Countries citing papers authored by Markus Weigandt

Since Specialization
Citations

This map shows the geographic impact of Markus Weigandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Weigandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Weigandt more than expected).

Fields of papers citing papers by Markus Weigandt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Weigandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Weigandt. The network helps show where Markus Weigandt may publish in the future.

Co-authorship network of co-authors of Markus Weigandt

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Weigandt. A scholar is included among the top collaborators of Markus Weigandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Weigandt. Markus Weigandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wagner, Christian, et al.. (2019). Application of an automated small-scale in vitro transfer model to predict in vivo precipitation inhibition. International Journal of Pharmaceutics. 565. 458–471. 6 indexed citations
2.
Wagner, Christian, Markus Weigandt, Christian Weber, et al.. (2019). Improved Prediction of in Vivo Supersaturation and Precipitation of Poorly Soluble Weakly Basic Drugs Using a Biorelevant Bicarbonate Buffer in a Gastrointestinal Transfer Model. Molecular Pharmaceutics. 16(9). 3938–3947. 24 indexed citations
3.
Wagner, Christian, et al.. (2018). Automated small-scale in vitro transfer model as screening tool for the prediction of in vivo-dissolution and precipitation of poorly solubles. International Journal of Pharmaceutics. 556. 150–158. 11 indexed citations
4.
Weigandt, Markus, et al.. (2016). The effect of polymer size and charge of molecules on permeation through synovial membrane and accumulation in hyaline articular cartilage. European Journal of Pharmaceutics and Biopharmaceutics. 101. 126–136. 35 indexed citations
5.
Breyer, Sandra, Simon Geißler, Walter Mier, et al.. (2013). How do in-vitro release profiles of nanosuspensions from Alzet® pumps correspond to the in-vivo situation? A case study on radiolabeled fenofibrate. Journal of Controlled Release. 168(1). 77–87. 11 indexed citations
6.
Geißler, Simon, et al.. (2013). In vitro–in vivo evaluation of nanosuspension release from subcutaneously implantable osmotic pumps. International Journal of Pharmaceutics. 451(1-2). 57–66. 9 indexed citations
7.
Miller, Tobias, Sandra Breyer, Walter Mier, et al.. (2013). Premature drug release of polymeric micelles and its effects on tumor targeting. International Journal of Pharmaceutics. 445(1-2). 117–124. 69 indexed citations
8.
Weigandt, Markus, et al.. (2013). Crystal suspensions of poorly soluble peptides for intra-articular application: A novel approach for biorelevant assessment of their in vitro release. International Journal of Pharmaceutics. 461(1-2). 46–53. 10 indexed citations
9.
Miller, Tobias, et al.. (2012). Analysis of Immediate Stress Mechanisms upon Injection of Polymeric Micelles and Related Colloidal Drug Carriers. University of Regensburg Publication Server (University of Regensburg). 1 indexed citations
10.
Miller, Tobias, et al.. (2012). Drug Loading of Polymeric Micelles. Pharmaceutical Research. 30(2). 584–595. 49 indexed citations
11.
Geißler, Simon, et al.. (2012). Development of a New Method to Assess Nanocrystal Dissolution Based on Light Scattering. Pharmaceutical Research. 29(10). 2887–2901. 38 indexed citations
12.
13.
Miller, Tobias, et al.. (2011). Comparative Investigations on In Vitro Serum Stability of Polymeric Micelle Formulations. Pharmaceutical Research. 29(2). 448–459. 60 indexed citations
14.
Weigandt, Markus, et al.. (2011). Comparison of different protein concentration techniques within preformulation development. International Journal of Pharmaceutics. 421(1). 120–129. 16 indexed citations
15.
Geißler, Simon, et al.. (2011). Controlled delivery of nanosuspensions from osmotic pumps: Zero order and non-zero order kinetics. Journal of Controlled Release. 158(3). 403–412. 24 indexed citations
16.
Weigandt, Markus, et al.. (2009). Relevant shaking stress conditions for antibody preformulation development. European Journal of Pharmaceutics and Biopharmaceutics. 74(2). 139–147. 47 indexed citations
17.
Weigandt, Markus. (2001). Der Humane Vollblut-Pyrogentest - Optimierung, Validierung und Vergleich mit den Arzneibuchmethoden. 2 indexed citations
18.
Fennrich, Stefan, Matthias Fischer, Thomas Härtung, et al.. (1999). Detection of endotoxins and other pyrogens using human whole blood.. PubMed. 101. 131–9. 59 indexed citations
19.
Fennrich, Stefan, Matthias Fischer, Thomas Härtung, et al.. (1998). [Evaluation and further development of a pyrogenicity assay based on human whole blood]. PubMed. 15(3). 123–128. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026